Multiple roles for the Wilms' tumor suppressor, WT1

Cancer Research

Volumn 59, Issue 7 SUPPL., 1999, Pages

  Davies, Rachel ^a   Moore, Adrian ^a   Schedl, Andreas ^a   Bratt, Eva ^a   Miyahawa, Kiyoshi ^a   Ladomery, Michael ^a   Miles, Colin ^a   Menke, Aswin ^a   Van Heyningen, Veronica ^a   Hastie, Nicholas ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; TRANSCRIPTION FACTOR; ZINC FINGER PROTEIN;

BLASTEMA; CARCINOGENESIS; CHILDHOOD CANCER; CONFERENCE PAPER; DNA FLANKING REGION; GENE FUNCTION; GENE MUTATION; HUMAN; KIDNEY DEVELOPMENT; NEPHROBLASTOMA; ORGANOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; TUMOR SUPPRESSOR GENE;

ALTERNATIVE SPLICING; ANIMALS; CHROMOSOMES, ARTIFICIAL, YEAST; GENES, TUMOR SUPPRESSOR; GENES, WILMS TUMOR; HUMANS; TRANSCRIPTION, GENETIC;

EID: 17744416394     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Hastie, N. D. The genetics of Wilms' tumor: a case of disrupted development. Annu. Rev. Genet., 28: 523-558, 1994.
2. Call, K. M., Glaser, T., Ito, C. Y., Buckler, A. J., Pelletier, J., Haber, D. A., Rose, E. A., Kral, A., Yeger, H., Lewis, W. H., Jones, C., and Housman, D. E. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell, 60: 509-520, 1990.
3. Gessler, M., Poustka, A., Cavenee, W., Neve, R. L., Orkin, S. H., and Bruns, G. Homozygous deletion in Wilms' tumours of a zinc-finger gene identified by chromosome jumping. Nature (Lond.), 343: 774-778, 1990.
4. Ogawa, O., Eccles, M. R., Szeto, J., McNoe, L. A., Yun, K., et al. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature (Lond.), 362: 749-751, 1993.
5. Rainer, S., Johnston, L. A., Dorby, C. J., Ping, A. J., Grundy, P. E., and Feinberg, A. P. Relaxation of imprinted genes in human cancer. Nature (Lond.), 362: 747-749, 1993.
6. Sun, F.-L., Dean, W. L., Kelsey, G., Allen, N. D., and Reik, W. Transactivation of Ifg2 in a mouse model of Beckwith-Wiedemann syndrome. Nature (Lond.), 389: 809-815, 1997.
7. Hastie, N. D. Disomy and disease resolved? Nature, News and Views, 389: 785-787, 1997.
8. Pritchard-Jones, K., Fleming, S., Davidson, D., Bickmore, W., Porteous, D. J., Gosden, C., Bard, J., Buckler, A., Pelletier, J., Housman, D., Van Heyningen, V., and Hastie, N. The candidate Wilms' tumour gene is involved in genitourinary development. Nature (Lond.), 346: 194-197, 1990.
9. Schumacher, V., Schneider, S., Figge, A., Wildhardt, G., Harms, D., Schmidt, D., Weirich, A., Ludwig, R., and Royer-Pokora, B. Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms' tumors of stromal-predominant histology. Proc. Natl. Acad. Sci. USA, 94: 3972-3977, 1997.
10. Miyagawa, K., Kent, J., Moore, A., Charlieu, J-P., Little, M. H., Williamson, K. A., Kelsey, A., Brown, K., Hassam, S., Briner, J., Hayashi, Y., Hirai, H., Yazaki, Y., Van Heyningen, V., and Hastie, N. D. Loss of WT1 function leads to ectopic myogenesis in Wilms' tumour. Nat. Genet., 18: 15-17, 1997.
11. Miles, C., Elgar, G., Coles, E., Kleinjan, D-J., Van Heyningen, V., and Hastie, N. D. Complete sequencing of the Fugu WAGR region from WT1 to PAX6 - dramatic compaction and conservation of synteny with human chromosome 11p13. Proc. Natl. Acad. Sci. USA, 95: 13068-13072, 1998.
12. Rauscher, F. J., III. The WT1 Wilms' tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor. FASEB J., 7: 896-903, 1993.
13. Larsson, S. H., Charlieu, J. P., Miyagawa, K., Engelkamp, D., Rassoulzadegan, M., Ross, A., Cuzin, F., van Heyningen, V., and Hastie, N. D. Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternatice splicing. Cell, 81: 391-401, 1995.
14. Barbaux, S., Niaudet, P., Gubler, M-C., Grunfeld, J-P., Jaubert, F., Kuttenn, F., Fekete, C. N., Souleyreau-Therville, N., Thibaud, E., Fellous, M., and McElreavey. K. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat. Genet., 17: 467-470, 1997.
15. van Heyningen, V. Sugar and spice and all things splice? Nat. Genet., 17: 367-368, 1997.
16. Bickmore, W. A., Oghene, K., Little, M. H., Seawright, A., van Heyningen, V., and Hastie, N. D. Modulation of DNA binding specificity by alternative splicing of the Wilms' tumor wt1 gene transcript. Science (Washington DC), 257: 235-237, 1992.
17. Drummond, I. A., Rupprecht, H. D., Rohwer-Nutter, P., Lopez-Guisa, J. M., Madden, S. L., Rauscher, F. J., III, and Sukhatme, V. P. DNA recognition by splicing variants of the Wilms' tumour suppressor, WT1. Mol. Cell. Biol., 14: 3800-3809, 1994.
18. Menke, A. L., Van der Eb, A. J., and Jochemsen, A. G. The Wilms' tumor gene: oncogene or tumor suppressor gene? Int. Rev. of Cyt., 181: 151-212, 1998.
19. Caricasole, A., Duarte, A., Larsson, S. H., Hastie, N. D., Little, M., Holmes, G., Todorov, I., and Ward, A. RNA binding by the Wilms' tumor suppressor zinc finger proteins. Proc. Natl. Acad. Sci. USA, 93: 7562-7566, 1996.
20. Bardeesy, N., and Pelletier, J. Overlapping RNA and DNA binding domains of the wt1 tumor suppressor gene product. Nucleic Acids Res., 26: 1784-1792, 1998.
21. Kennedy, D., Ramsdale, T., Mattick, J., and Little, M. An RNA recognition motif in Wilms' tumor protein (WT1) revealed by structural modelling. Nat. Genet., 12: 329-332, 1996.
22. Davies, R. C., Calvo, C., Bratt, E., Larsson, S., Lamond, A. I., and Hastie, N. D. WT1 interacts with the splicing factor U2AF65 in an isoform dependent manner and can be incorporated into spliceosomes. Genes Dev., 12: 3217-3225, 1998.
23. Kreidberg, J. A., Sariola, H., Loring, J. M., Maeda, M., Pelletier, J., Housmann, D., and Jaenisch, R. WT-1 is required for early kidney development. Cell, 74: 679-691, 1993.
24. Menke, A., McInnes L., Hastie, N. D., and Schedl, A. The Wilms' tumor suppressor WT1: approaches to gene function. Kidney Int., 53: 1512-1518, 1998.
25. Moore, A., Schedl, A., McInnes, L., Doyle, M., Hecksher-Sorensen, J., and Hastie, N. D. YAC transgenic analysis reveals Wilms' Tumour 1 gene activity in the proliferating coelomic epithelium, developing diaphragm and limb. MOD, 79: 169-184, 1998.
26. Moore, A. W., McInnes, L., Kreidberg, J., Hastie, N. D., and Schedl, A. YAC complementation shows a requirement for Wt1 in the development of epicardium, adrenal gland and throughout nephrogenesis. Development, in press, 1999.